|

Whole-life Investigation of Lishui Longevity

RECRUITINGSponsored by The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital
Actively Recruiting
SponsorThe Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital
Started2026-05-18
Est. completion2036-05-31
Eligibility
Age30 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07592962

Summary

1. To establish a standardized, normalized and scientific joint screening and follow-up management system for chronic disease multimorbidity in Lishui City, and early identify common risk factors of major chronic diseases such as cardiovascular and cerebrovascular diseases and tumors. 2. To carry out targeted intervention and long-term follow-up for high-risk populations, reduce the incidence risk of major chronic diseases in the target population, improve residents' health status and grassroots comprehensive prevention and treatment capacity of chronic diseases, and provide scientific evidence and practical support for the construction of Healthy Lishui.

Eligibility

Age: 30 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Aged 30 to 80 years old; male-to-female ratio of 1:1; permanent residents in Lishui City; physically healthy; voluntary participation in the project with signed informed consent.

Exclusion Criteria:

* Individuals ever diagnosed with malignant tumors or cardiovascular and cerebrovascular diseases by physicians or other health professionals; those with unstable vital signs or an expected survival time of less than 3 months; participants with incomplete basic information, and those unable to cooperate with subsequent follow-up.

Conditions4

CardiovascularChronic DiseaseIschemic StrokeLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.